PTHS
Pelthos Therapeutics Inc.
NYSE MKT: PTHS · HEALTHCARE · BIOTECHNOLOGY
$25.09
+0.48% today
Updated 2026-04-29
Market cap
$83.79M
P/E ratio
—
P/S ratio
4.99x
EPS (TTM)
$-23.04
Dividend yield
—
52W range
$9 – $38
Volume
0.0M
Pelthos Therapeutics Inc. (PTHS) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$25.09
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$21.47
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -257.90%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.